Companies
Companies
Novartis Boosts Portfolio with Monjuvi Acquisition
📰 Novartis acquires MorphoSys, gaining access to Monjuvi for lymphoma treatment. 🤝 Strengthens portfolio, expands biotech presence. 😊 Incyte benefits from collaboration agreement. 💼 Reflects global biotech growth.
Samsung Biologics and LegoChem unite to revolutionize cancer treatment
🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.
BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments
📢 BioNTech and Autolus join forces in a $250m deal to revolutionize CAR-T cell therapies for cancer treatment. 💼🔬💪
Revolutionary Partnership Speeds Up mRNA Analysis!
🧪📈 Lonza and Oxford Nanopore join forces to revolutionize mRNA analysis in the fast-paced biotech sector. Exciting times ahead!
Gene Therapy Breakthrough Acquisition and Bankruptcy Shake Biotech Industry!
📰 Intellia and Ultragenyx's clinical updates, Novo Holdings' Catalent acquisition, and NanoString bankruptcy; Simon Barnett 💊💼💥💡
Cambridge Start-Up Bags £225m for Carbon-Negative Biofuel
🌿 British-Malasian marine algae start-up, HutanBio, bags £2.25m seed financing to produce carbon-negative biodiesel. 🌊💰
Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼
EU Parliament Backs New Genome Techniques in Plant Breeding: What You Need to Know
🌱 MEPs support rules distinguishing NGT breeds, 307 votes to 263, with 41 abstentions. 🚫 Ban on patents, mandatory labeling, and organic farming. ✅ NGT1 exempt from GMO requirements. ⚖️ Commission and Council to decide, opposition from Poland may delay approval.
Game-Changing Merger Propels Biovian and 3P Globally
🔎 CDMOs Biovian and 3P merge to expand globally, covering the entire biotech development process. 🌍💼🤝📈
Evotec’s Breakthrough: Expanding HIV Antibody Deal
📰 Evotec expands anti-HIV antibody deal with ABL to develop and manufacture neutralizing antibodies against HIV. Just-Evotec Biologics to develop third antibody and provide manufacturing services for Phase I clinical study. Partnership aims to deliver new HIV therapies. 💉🌍
